Middeldifferencen af vægttab hos orlistatbehandlede patienter sammenlignet med placebo var 1, 83 kg til 3, 06 kg og middeldifferencen mellem placebo og HbA1c- reduktion var 0, 18% til 0, 55%.
In orlistat-treated patients, the mean difference from placebo in weight loss was 1.83 kg to 3.06 kg and the mean difference from placebo in HbA1c reduction was 0.18% to 0.55%.